Zurcher Kantonalbank Zurich Cantonalbank Purchases Shares of 14,010 Everus (NYSE:ECG)

Zurcher Kantonalbank Zurich Cantonalbank bought a new stake in Everus (NYSE:ECG - Free Report) during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund bought 14,010 shares of the company's stock, valued at approximately $921,000.

Several other institutional investors and hedge funds have also recently bought and sold shares of ECG. SRS Capital Advisors Inc. acquired a new position in shares of Everus in the fourth quarter valued at approximately $26,000. Principal Securities Inc. acquired a new position in Everus in the 4th quarter valued at $27,000. HighMark Wealth Management LLC purchased a new position in Everus during the 4th quarter worth $28,000. Crews Bank & Trust acquired a new stake in shares of Everus in the 4th quarter worth $29,000. Finally, Mendota Financial Group LLC purchased a new stake in shares of Everus in the fourth quarter valued at about $36,000.

Insider Buying and Selling

In other news, CFO Maximillian J. Marcy purchased 1,300 shares of the firm's stock in a transaction on Tuesday, February 25th. The shares were bought at an average cost of $38.99 per share, with a total value of $50,687.00. Following the purchase, the chief financial officer now directly owns 5,508 shares of the company's stock, valued at approximately $214,756.92. This trade represents a 30.89 % increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Edward A. Ryan purchased 1,400 shares of the business's stock in a transaction on Tuesday, February 25th. The stock was acquired at an average price of $38.02 per share, with a total value of $53,228.00. Following the completion of the acquisition, the director now directly owns 14,928 shares in the company, valued at $567,562.56. The trade was a 10.35 % increase in their position. The disclosure for this purchase can be found here. Insiders purchased 3,750 shares of company stock worth $153,853 in the last ninety days.

Remove Ads

Analysts Set New Price Targets

Several research analysts recently issued reports on ECG shares. Wolfe Research assumed coverage on shares of Everus in a report on Tuesday, December 3rd. They set a "peer perform" rating for the company. Oppenheimer increased their target price on Everus from $70.00 to $80.00 and gave the stock an "outperform" rating in a research note on Tuesday, January 7th. Finally, Stifel Nicolaus decreased their price target on Everus from $85.00 to $67.00 and set a "buy" rating on the stock in a research note on Thursday, February 13th.

Everus Trading Up 5.6 %

ECG traded up $2.21 on Monday, hitting $41.42. 491,535 shares of the company were exchanged, compared to its average volume of 714,892. Everus has a fifty-two week low of $36.96 and a fifty-two week high of $77.93. The company has a current ratio of 1.58, a quick ratio of 1.50 and a debt-to-equity ratio of 0.47. The business has a fifty day moving average price of $54.38.

Everus (NYSE:ECG - Get Free Report) last released its quarterly earnings results on Tuesday, February 11th. The company reported $0.67 earnings per share for the quarter, missing analysts' consensus estimates of $0.73 by ($0.06). On average, research analysts predict that Everus will post 2.49 earnings per share for the current fiscal year.

Everus Profile

Everus Construction Group is providing a full spectrum of construction services through its electrical and mechanical and transmission and distribution specialty contracting services principally in United States. Its specialty contracting services are provided to utility, transportation, commercial, industrial, institutional, renewable and other customers.